Literature DB >> 27692558

Impact of omega-3 polyunsaturated fatty acids on vascular function and blood pressure: Relevance for cardiovascular outcomes.

G Colussi1, C Catena1, M Novello1, N Bertin1, L A Sechi2.   

Abstract

AIMS: To overview the effects of omega-3 polyunsaturated fatty acids (PUFA) on blood vessels and blood pressure (BP) and their relevance for cardiovascular prevention. DATA SYNTHESIS: The importance of omega-3 PUFA for the cardiovascular system has come under the spotlight during the last decades. These fatty acids are present in variable amounts in cell membranes of mammal species, and their content affects a variety of cellular functions. Evidence obtained in animal and human studies suggests that omega-3 PUFA affect many steps of the atherosclerotic process. In blood vessels, omega-3 PUFA improve endothelial function; promote vasodilatation through relaxation of smooth muscle cells; exert antioxidant, anti-inflammatory, and antithrombotic actions; delay development of plaques and increase their stability; and decrease wall stiffening. Omega-3 PUFA might affect BP, and studies conducted with ambulatory monitoring suggest that supplementation with these fatty acids decreases the average 24-h BP levels. This effect on BP is related to the pretreatment membrane content of omega-3 PUFA, and this might explain some inconsistencies among intervention trials. Meta-analyses indicate that omega-3 PUFA have a mild but significant BP lowering effect. While encouraging results were initially obtained with the use of omega-3 PUFA supplements in secondary prevention trials, meta-analyses have not confirmed the ability of these fatty acids to decrease the risk of coronary heart and cerebrovascular disease.
CONCLUSIONS: Omega-3 PUFA are associated with significant improvement in vascular function and lowering of BP. However, the evidence currently supporting the role of these fatty acids in cardiovascular prevention is weak and needs further investigation.
Copyright © 2016 The Italian Society of Diabetology, the Italian Society for the Study of Atherosclerosis, the Italian Society of Human Nutrition, and the Department of Clinical Medicine and Surgery, Federico II University. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Cardiovascular risk; Fatty acids; Hypertension; Meta-analysis

Mesh:

Substances:

Year:  2016        PMID: 27692558     DOI: 10.1016/j.numecd.2016.07.011

Source DB:  PubMed          Journal:  Nutr Metab Cardiovasc Dis        ISSN: 0939-4753            Impact factor:   4.222


  25 in total

1.  α-Linolenic acid and exercise training independently, and additively, decrease blood pressure and prevent diastolic dysfunction in obese Zucker rats.

Authors:  Pierre-Andre Barbeau; Tanya M Holloway; Jamie Whitfield; Brittany L Baechler; Joe Quadrilatero; Luc J C van Loon; Adrian Chabowski; Graham P Holloway
Journal:  J Physiol       Date:  2017-05-24       Impact factor: 5.182

2.  Sea food consumption for improving cardiac and cerebral manifestations of mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes.

Authors:  Fulvio A Scorza; Josef Finsterer
Journal:  Ann Transl Med       Date:  2017-09

3.  Low levels of linoleic acid and α-linolenic acid and high levels of arachidonic acid in plasma phospholipids are associated with hypertension.

Authors:  Ikuyo Tsukamoto; Shiori Sugawara
Journal:  Biomed Rep       Date:  2017-11-08

4.  Vitamin D, Marine n-3 Fatty Acids, and Primary Prevention of Cardiovascular Disease Current Evidence.

Authors:  JoAnn E Manson; Shari S Bassuk; Nancy R Cook; I-Min Lee; Samia Mora; Christine M Albert; Julie E Buring
Journal:  Circ Res       Date:  2020-01-02       Impact factor: 17.367

5.  Multi-Tissue Multi-Omics Nutrigenomics Indicates Context-Specific Effects of Docosahexaenoic Acid on Rat Brain.

Authors:  Guanglin Zhang; Qingying Meng; Montgomery Blencowe; Rahul Agrawal; Fernando Gomez-Pinilla; Xia Yang
Journal:  Mol Nutr Food Res       Date:  2020-10-15       Impact factor: 5.914

6.  Quantitative determination of EPA and DHA in fish oil capsules for cardiovascular disease therapy in Indonesia by GC-MS.

Authors:  Amelia Lorensia; Ryanto Budiono; Rivan Virlando Suryadinata; Navy Tiarasari
Journal:  J Public Health Res       Date:  2021-04-14

Review 7.  Protective Effects of ω-3 PUFA in Anthracycline-Induced Cardiotoxicity: A Critical Review.

Authors:  Simona Serini; Renata Ottes Vasconcelos; Renata Nascimento Gomes; Gabriella Calviello
Journal:  Int J Mol Sci       Date:  2017-12-12       Impact factor: 5.923

Review 8.  Enriching Diet with n-3 PUFAs to Help Prevent Cardiovascular Diseases in Healthy Adults: Results from Clinical Trials.

Authors:  Matteo Manuelli; Lucio Della Guardia; Hellas Cena
Journal:  Int J Mol Sci       Date:  2017-07-18       Impact factor: 5.923

9.  Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistance.

Authors:  Julia M Houthuijzen; Ilse Oosterom; Brian D Hudson; Akira Hirasawa; Laura G M Daenen; Chelsea M McLean; Steffen V F Hansen; Marijn T M van Jaarsveld; Daniel S Peeper; Sahar Jafari Sadatmand; Jeanine M L Roodhart; Chris H A van de Lest; Trond Ulven; Kenji Ishihara; Graeme Milligan; Emile E Voest
Journal:  FASEB J       Date:  2017-02-09       Impact factor: 5.191

10.  Comparative Effect of Statins and Omega-3 Supplementation on Cardiovascular Events: Meta-Analysis and Network Meta-Analysis of 63 Randomized Controlled Trials Including 264,516 Participants.

Authors:  Tung Hoang; Jeongseon Kim
Journal:  Nutrients       Date:  2020-07-25       Impact factor: 5.717

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.